Liyang (Sarah) Cui, Ph.D.
Liyang (Sarah) Cui, Ph.D.
Education and Professional Training:
Ph.D. in Medical Biophysics 2010-2015
University of Toronto, 2011-2015 Supervisor: Dr. Gang Zheng
Medical School of Peking University, 2010-2011 Supervisor: Dr. Fan Wang
B.Sc. in Biology & Chemistry 2006-2009
Jilin University, China
Recent Publications:
1. Muhanna N,
Cui L, Chan H, Burgess L, Jin CS, MacDonald TD, Huynh E, Wang F, Chen J, Irish JC, Zheng G. Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage.
Clin Cancer Res. 2016 Feb 15;22(4):961-70. doi: 10.1158/1078-0432.CCR-15-1235. (Co-first author, Cover article)
2. Muhanna N, Jin CS, Huynh E, Chan H, Qiu Y, Jiang W,
Cui L, Burgess L, Akens MK, Chen J, Irish JC, Zheng G. Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.
Theranostics. 2015 Oct 18;5(12):1428-43. doi:10.7150/thno.13451.
3.
Cui L, Tokarz D, Cisek R, Ng KK, Wang F, Chen J, Barzda V, Zheng G. Organized Aggregation of Porphyrins in Lipid Bilayers for Third Harmonic Generation Microscopy.
Angew Chem Int Ed Engl. 2015 Nov 16;54(47):13928-32. doi: 10.1002/anie.201506171.
4.
Cui L, Lin Q, Jin CS, Jiang W, Huang H, Ding L, Muhanna N, Irish JC, Wang F, Chen J, Zheng G.A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
ACS Nano. 2015;9(4):4484-95. doi:10.1021/acsnano.5b01077.
5. Muhanna N, MacDonald TD, Chan H, Jin CS, Burgess L,
Cui L, Chen J, Irish JC, Zheng G. Multimodal Nanoparticle for Primary Tumor Delineation and Lymphatic Metastasis Mapping in a Head-and-Neck Cancer Rabbit Model.
Adv Healthc Mater. 2015 Aug 18. doi: 10.1002/adhm.201500363.
6. Ma T, Sun X,
Cui L, Gao L, Wu Y, Liu H, Zhu Z, Wang F, Liu Z. Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.
J Nucl Med. 2014 Jun;55(6):1002-7. doi: 10.2967/jnumed.114.137000.
7. Jin CS,
Cui L, Wang F, Chen J, Zheng G. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.
Adv Healthc Mater. 2014 Aug;3(8):1240-9. doi: 10.1002/adhm.201300651. (Co-first author, Cover article)
8. Dong C, Zhao H, Yang S, Shi J, Huang J,
Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Mol Pharm. 2013 Aug 5;10(8):2925-33. doi: 10.1021/mp400040z.
9. Shi J,
Cui L, Jia B, Liu Z, He P, Dong C, Jin X, Zhao H, Li F, Wang F.Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignancies.
Mol Imaging. 2013 Jul-Aug;12(5):318-26.
10.
Cui L, Liu Z, Jin X, Jia B, Li F, Wang F. Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy.
Nucl Med Biol. 2013 Feb;40(2):182-9. doi: 10.1016/j.nucmedbio.2012.11.002.
11. Liu Z, Huang J, Dong C,
Cui L, Jin X, Jia B, Zhu Z, Li F, Wang F. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Mol Pharm. 2012 May 7;9(5):1409-17. doi: 10.1021/mp200661t.
12. Huang J,
Cui L, Wang F, Liu Z. PET tracers based on (86)Y.
Curr Radiopharm. 2011 Apr;4(2):122-30.